192456-37-4

Basic information

• Product Name: [αS(αR*,γR*,δR*)]-γ-Hydroxy-δ-[(4-methylcyclohexyl)amino]-α-(1-methylethyl)-N-(2-methylpropyl)cyclohexanehexanamide
• Synonyms: [αS(αR*,γR*,δR*)]-γ-Hydroxy-δ-[(4-methylcyclohexyl)amino]-α-(1-methylethyl)-N-(2-methylpropyl)cyclohexanehexanamide
• CAS NO: 192456-37-4
• Molecular Weight: 422.695
• Mol File: 192456-37-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [αS(αR*,γR*,δR*)]-γ-Hydroxy-δ-[(4-methylcyclohexyl)amino]-α-(1-methylethyl)-N-(2-methylpropyl)cyclohexanehexanamide(CAS DataBase Reference)
• NIST Chemistry Reference: [αS(αR*,γR*,δR*)]-γ-Hydroxy-δ-[(4-methylcyclohexyl)amino]-α-(1-methylethyl)-N-(2-methylpropyl)cyclohexanehexanamide(192456-37-4)
• EPA Substance Registry System: [αS(αR*,γR*,δR*)]-γ-Hydroxy-δ-[(4-methylcyclohexyl)amino]-α-(1-methylethyl)-N-(2-methylpropyl)cyclohexanehexanamide(192456-37-4)

Safety Data

• Hazardous Substances Data: 192456-37-4(Hazardous Substances Data)

Upstream product

• 1336-21-6 ammonium hydroxide 
• 75-09-2 dichloromethane 
• 589-92-4 1-methylcyclohexan-4-one 

Relevant articles and documents

5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of β-amyloid protein production

A series of 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives of Formula I have been synthesized. STR1 As inhibitors of the production of β-amyloid protein from β-amyloid precursor protein, these compounds are expected to be effective in treating patients suffering from or susceptible to conditions or disorders linked to brain accumulation of β-amyloid protein; e.g., Alzheimer's Disease and Down's Syndrome.